nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—Ezetimibe—coronary artery disease	0.618	1	CbGbCtD
Lorazepam—Diclofenac—PLA2G2A—coronary artery disease	0.00136	0.258	CrCbGaD
Lorazepam—Chlorthalidone—CA5B—coronary artery disease	0.00133	0.252	CrCbGaD
Lorazepam—Diclofenac—CXCL8—coronary artery disease	0.000403	0.0765	CrCbGaD
Lorazepam—Amoxapine—HTR7—coronary artery disease	0.000245	0.0465	CrCbGaD
Lorazepam—Bromazepam—CYP2C19—coronary artery disease	0.00021	0.0399	CrCbGaD
Lorazepam—Feeling abnormal—Olmesartan—coronary artery disease	0.00021	0.000713	CcSEcCtD
Lorazepam—Pain—Pravastatin—coronary artery disease	0.000209	0.000712	CcSEcCtD
Lorazepam—Constipation—Pravastatin—coronary artery disease	0.000209	0.000712	CcSEcCtD
Lorazepam—Rash—Acetylsalicylic acid—coronary artery disease	0.000209	0.000711	CcSEcCtD
Lorazepam—Hypersensitivity—Ezetimibe—coronary artery disease	0.000209	0.000711	CcSEcCtD
Lorazepam—Asthenia—Clopidogrel—coronary artery disease	0.000209	0.000711	CcSEcCtD
Lorazepam—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000209	0.000711	CcSEcCtD
Lorazepam—Confusional state—Losartan—coronary artery disease	0.000208	0.000709	CcSEcCtD
Lorazepam—Tension—Timolol—coronary artery disease	0.000208	0.000708	CcSEcCtD
Lorazepam—Asthenia—Lovastatin—coronary artery disease	0.000208	0.000706	CcSEcCtD
Lorazepam—Somnolence—Telmisartan—coronary artery disease	0.000208	0.000706	CcSEcCtD
Lorazepam—Nervousness—Timolol—coronary artery disease	0.000206	0.000701	CcSEcCtD
Lorazepam—Hypotension—Perindopril—coronary artery disease	0.000206	0.0007	CcSEcCtD
Lorazepam—Infection—Losartan—coronary artery disease	0.000205	0.000698	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000205	0.000698	CcSEcCtD
Lorazepam—Fatigue—Trandolapril—coronary artery disease	0.000205	0.000697	CcSEcCtD
Lorazepam—Fatigue—Enalapril—coronary artery disease	0.000204	0.000694	CcSEcCtD
Lorazepam—Asthenia—Ezetimibe—coronary artery disease	0.000204	0.000692	CcSEcCtD
Lorazepam—Tremor—Ramipril—coronary artery disease	0.000203	0.000692	CcSEcCtD
Lorazepam—Constipation—Trandolapril—coronary artery disease	0.000203	0.000691	CcSEcCtD
Lorazepam—Chills—Lisinopril—coronary artery disease	0.000203	0.00069	CcSEcCtD
Lorazepam—Nausea—Rosuvastatin—coronary artery disease	0.000203	0.00069	CcSEcCtD
Lorazepam—Thrombocytopenia—Losartan—coronary artery disease	0.000202	0.000688	CcSEcCtD
Lorazepam—Constipation—Enalapril—coronary artery disease	0.000202	0.000688	CcSEcCtD
Lorazepam—Arrhythmia—Lisinopril—coronary artery disease	0.000202	0.000687	CcSEcCtD
Lorazepam—Somnolence—Captopril—coronary artery disease	0.000202	0.000686	CcSEcCtD
Lorazepam—Tachycardia—Losartan—coronary artery disease	0.000202	0.000686	CcSEcCtD
Lorazepam—Feeling abnormal—Pravastatin—coronary artery disease	0.000202	0.000686	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000202	0.000685	CcSEcCtD
Lorazepam—Fatigue—Telmisartan—coronary artery disease	0.000201	0.000684	CcSEcCtD
Lorazepam—Hypotension—Furosemide—coronary artery disease	0.0002	0.000681	CcSEcCtD
Lorazepam—Vision blurred—Timolol—coronary artery disease	0.0002	0.00068	CcSEcCtD
Lorazepam—Alopecia—Lisinopril—coronary artery disease	0.0002	0.00068	CcSEcCtD
Lorazepam—Pain—Telmisartan—coronary artery disease	0.0002	0.000679	CcSEcCtD
Lorazepam—Constipation—Telmisartan—coronary artery disease	0.0002	0.000679	CcSEcCtD
Lorazepam—Agitation—Ramipril—coronary artery disease	0.0002	0.000679	CcSEcCtD
Lorazepam—Hypersensitivity—Simvastatin—coronary artery disease	0.000199	0.000678	CcSEcCtD
Lorazepam—Asthenia—Eplerenone—coronary artery disease	0.000199	0.000678	CcSEcCtD
Lorazepam—Nausea—Acetylsalicylic acid—coronary artery disease	0.000197	0.00067	CcSEcCtD
Lorazepam—Erythema—Lisinopril—coronary artery disease	0.000197	0.00067	CcSEcCtD
Lorazepam—Dizziness—Fenofibrate—coronary artery disease	0.000196	0.000666	CcSEcCtD
Lorazepam—Somnolence—Perindopril—coronary artery disease	0.000196	0.000666	CcSEcCtD
Lorazepam—Feeling abnormal—Trandolapril—coronary artery disease	0.000196	0.000666	CcSEcCtD
Lorazepam—Fatigue—Captopril—coronary artery disease	0.000196	0.000665	CcSEcCtD
Lorazepam—Vertigo—Ramipril—coronary artery disease	0.000195	0.000664	CcSEcCtD
Lorazepam—Feeling abnormal—Enalapril—coronary artery disease	0.000195	0.000663	CcSEcCtD
Lorazepam—Asthenia—Simvastatin—coronary artery disease	0.000194	0.00066	CcSEcCtD
Lorazepam—Constipation—Captopril—coronary artery disease	0.000194	0.00066	CcSEcCtD
Lorazepam—Tension—Lisinopril—coronary artery disease	0.000193	0.000657	CcSEcCtD
Lorazepam—Hypotension—Losartan—coronary artery disease	0.000193	0.000657	CcSEcCtD
Lorazepam—Dizziness—Clopidogrel—coronary artery disease	0.000193	0.000655	CcSEcCtD
Lorazepam—Feeling abnormal—Telmisartan—coronary artery disease	0.000192	0.000654	CcSEcCtD
Lorazepam—Dizziness—Lovastatin—coronary artery disease	0.000191	0.000651	CcSEcCtD
Lorazepam—Nervousness—Lisinopril—coronary artery disease	0.000191	0.000651	CcSEcCtD
Lorazepam—Vertigo—Timolol—coronary artery disease	0.000191	0.000649	CcSEcCtD
Lorazepam—Somnolence—Furosemide—coronary artery disease	0.00019	0.000648	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Perindopril—coronary artery disease	0.00019	0.000647	CcSEcCtD
Lorazepam—Fatigue—Perindopril—coronary artery disease	0.00019	0.000646	CcSEcCtD
Lorazepam—Diclofenac—CYP2C19—coronary artery disease	0.000189	0.0358	CrCbGaD
Lorazepam—Constipation—Perindopril—coronary artery disease	0.000188	0.000641	CcSEcCtD
Lorazepam—Pain—Perindopril—coronary artery disease	0.000188	0.000641	CcSEcCtD
Lorazepam—Vomiting—Fenofibrate—coronary artery disease	0.000188	0.000641	CcSEcCtD
Lorazepam—Hypersensitivity—Valsartan—coronary artery disease	0.000188	0.00064	CcSEcCtD
Lorazepam—Convulsion—Ramipril—coronary artery disease	0.000188	0.00064	CcSEcCtD
Lorazepam—Dizziness—Ezetimibe—coronary artery disease	0.000188	0.000638	CcSEcCtD
Lorazepam—Feeling abnormal—Captopril—coronary artery disease	0.000187	0.000636	CcSEcCtD
Lorazepam—Rash—Fenofibrate—coronary artery disease	0.000187	0.000635	CcSEcCtD
Lorazepam—Dermatitis—Fenofibrate—coronary artery disease	0.000187	0.000635	CcSEcCtD
Lorazepam—Headache—Fenofibrate—coronary artery disease	0.000186	0.000631	CcSEcCtD
Lorazepam—Vision blurred—Lisinopril—coronary artery disease	0.000186	0.000631	CcSEcCtD
Lorazepam—Vomiting—Clopidogrel—coronary artery disease	0.000185	0.00063	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000185	0.000629	CcSEcCtD
Lorazepam—Fatigue—Furosemide—coronary artery disease	0.000185	0.000628	CcSEcCtD
Lorazepam—Tremor—Lisinopril—coronary artery disease	0.000185	0.000628	CcSEcCtD
Lorazepam—Vomiting—Lovastatin—coronary artery disease	0.000184	0.000626	CcSEcCtD
Lorazepam—Somnolence—Losartan—coronary artery disease	0.000184	0.000625	CcSEcCtD
Lorazepam—Dizziness—Eplerenone—coronary artery disease	0.000184	0.000625	CcSEcCtD
Lorazepam—Rash—Clopidogrel—coronary artery disease	0.000184	0.000625	CcSEcCtD
Lorazepam—Dermatitis—Clopidogrel—coronary artery disease	0.000183	0.000624	CcSEcCtD
Lorazepam—Asthenia—Valsartan—coronary artery disease	0.000183	0.000624	CcSEcCtD
Lorazepam—Hypertension—Timolol—coronary artery disease	0.000183	0.000623	CcSEcCtD
Lorazepam—Pain—Furosemide—coronary artery disease	0.000183	0.000623	CcSEcCtD
Lorazepam—Constipation—Furosemide—coronary artery disease	0.000183	0.000623	CcSEcCtD
Lorazepam—Hypersensitivity—Niacin—coronary artery disease	0.000183	0.000623	CcSEcCtD
Lorazepam—Clotiazepam—CYP2C19—coronary artery disease	0.000183	0.0347	CrCbGaD
Lorazepam—GABRG2—Ion channel transport—ATP2A2—coronary artery disease	0.000183	0.00222	CbGpPWpGaD
Lorazepam—Asthenia—Olmesartan—coronary artery disease	0.000183	0.000621	CcSEcCtD
Lorazepam—Headache—Clopidogrel—coronary artery disease	0.000182	0.000621	CcSEcCtD
Lorazepam—Rash—Lovastatin—coronary artery disease	0.000182	0.00062	CcSEcCtD
Lorazepam—Dermatitis—Lovastatin—coronary artery disease	0.000182	0.00062	CcSEcCtD
Lorazepam—Feeling abnormal—Perindopril—coronary artery disease	0.000182	0.000618	CcSEcCtD
Lorazepam—Headache—Lovastatin—coronary artery disease	0.000181	0.000616	CcSEcCtD
Lorazepam—Dry mouth—Ramipril—coronary artery disease	0.000181	0.000615	CcSEcCtD
Lorazepam—Vomiting—Ezetimibe—coronary artery disease	0.00018	0.000614	CcSEcCtD
Lorazepam—Hypersensitivity—Pravastatin—coronary artery disease	0.00018	0.000613	CcSEcCtD
Lorazepam—Dizziness—Simvastatin—coronary artery disease	0.000179	0.000609	CcSEcCtD
Lorazepam—Rash—Ezetimibe—coronary artery disease	0.000179	0.000608	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000179	0.00217	CbGpPWpGaD
Lorazepam—Dermatitis—Ezetimibe—coronary artery disease	0.000179	0.000608	CcSEcCtD
Lorazepam—Confusional state—Ramipril—coronary artery disease	0.000179	0.000608	CcSEcCtD
Lorazepam—Asthenia—Niacin—coronary artery disease	0.000178	0.000606	CcSEcCtD
Lorazepam—Fatigue—Losartan—coronary artery disease	0.000178	0.000606	CcSEcCtD
Lorazepam—Headache—Ezetimibe—coronary artery disease	0.000178	0.000605	CcSEcCtD
Lorazepam—Vertigo—Lisinopril—coronary artery disease	0.000177	0.000602	CcSEcCtD
Lorazepam—Dry mouth—Timolol—coronary artery disease	0.000177	0.000601	CcSEcCtD
Lorazepam—Constipation—Losartan—coronary artery disease	0.000177	0.000601	CcSEcCtD
Lorazepam—Pain—Losartan—coronary artery disease	0.000177	0.000601	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—GK—coronary artery disease	0.000177	0.00215	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LDHA—coronary artery disease	0.000177	0.00215	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HMGCS2—coronary artery disease	0.000177	0.00215	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GYG1—coronary artery disease	0.000177	0.00215	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PFKM—coronary artery disease	0.000177	0.00215	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GATM—coronary artery disease	0.000177	0.00215	CbGpPWpGaD
Lorazepam—Vomiting—Eplerenone—coronary artery disease	0.000177	0.000601	CcSEcCtD
Lorazepam—Feeling abnormal—Furosemide—coronary artery disease	0.000177	0.0006	CcSEcCtD
Lorazepam—Nausea—Fenofibrate—coronary artery disease	0.000176	0.000599	CcSEcCtD
Lorazepam—Asthenia—Pravastatin—coronary artery disease	0.000176	0.000597	CcSEcCtD
Lorazepam—Rash—Eplerenone—coronary artery disease	0.000175	0.000596	CcSEcCtD
Lorazepam—Hypersensitivity—Trandolapril—coronary artery disease	0.000175	0.000595	CcSEcCtD
Lorazepam—Dermatitis—Eplerenone—coronary artery disease	0.000175	0.000595	CcSEcCtD
Lorazepam—Confusional state—Timolol—coronary artery disease	0.000175	0.000594	CcSEcCtD
Lorazepam—Hypersensitivity—Enalapril—coronary artery disease	0.000174	0.000593	CcSEcCtD
Lorazepam—Headache—Eplerenone—coronary artery disease	0.000174	0.000592	CcSEcCtD
Lorazepam—Thrombocytopenia—Ramipril—coronary artery disease	0.000174	0.00059	CcSEcCtD
Lorazepam—Nausea—Clopidogrel—coronary artery disease	0.000173	0.000588	CcSEcCtD
Lorazepam—Tachycardia—Ramipril—coronary artery disease	0.000173	0.000588	CcSEcCtD
Lorazepam—Infection—Timolol—coronary artery disease	0.000172	0.000585	CcSEcCtD
Lorazepam—Vomiting—Simvastatin—coronary artery disease	0.000172	0.000585	CcSEcCtD
Lorazepam—Hypersensitivity—Telmisartan—coronary artery disease	0.000172	0.000585	CcSEcCtD
Lorazepam—Nausea—Lovastatin—coronary artery disease	0.000172	0.000584	CcSEcCtD
Lorazepam—Rash—Simvastatin—coronary artery disease	0.000171	0.00058	CcSEcCtD
Lorazepam—Dermatitis—Simvastatin—coronary artery disease	0.00017	0.00058	CcSEcCtD
Lorazepam—Asthenia—Trandolapril—coronary artery disease	0.00017	0.00058	CcSEcCtD
Lorazepam—Feeling abnormal—Losartan—coronary artery disease	0.00017	0.000579	CcSEcCtD
Lorazepam—Asthenia—Enalapril—coronary artery disease	0.00017	0.000577	CcSEcCtD
Lorazepam—Headache—Simvastatin—coronary artery disease	0.00017	0.000577	CcSEcCtD
Lorazepam—GABRB3—Orphan transporters—APOB—coronary artery disease	0.00017	0.00206	CbGpPWpGaD
Lorazepam—Dizziness—Valsartan—coronary artery disease	0.000169	0.000575	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—GCH1—coronary artery disease	0.000169	0.00205	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AK1—coronary artery disease	0.000169	0.00205	CbGpPWpGaD
Lorazepam—Nausea—Ezetimibe—coronary artery disease	0.000169	0.000573	CcSEcCtD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000168	0.00205	CbGpPWpGaD
Lorazepam—Dizziness—Olmesartan—coronary artery disease	0.000168	0.000572	CcSEcCtD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000168	0.00204	CbGpPWpGaD
Lorazepam—Quazepam—CYP2C19—coronary artery disease	0.000168	0.0318	CrCbGaD
Lorazepam—Asthenia—Telmisartan—coronary artery disease	0.000167	0.00057	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000167	0.00203	CbGpPWpGaD
Lorazepam—GABRG2—Orphan transporters—APOB—coronary artery disease	0.000166	0.00202	CbGpPWpGaD
Lorazepam—Hypotension—Ramipril—coronary artery disease	0.000166	0.000563	CcSEcCtD
Lorazepam—Nausea—Eplerenone—coronary artery disease	0.000165	0.000561	CcSEcCtD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000165	0.002	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—KCNJ2—coronary artery disease	0.000165	0.002	CbGpPWpGaD
Lorazepam—GABRA1—Orphan transporters—PLG—coronary artery disease	0.000165	0.002	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000165	0.002	CbGpPWpGaD
Lorazepam—Dizziness—Niacin—coronary artery disease	0.000164	0.000559	CcSEcCtD
Lorazepam—Dry mouth—Lisinopril—coronary artery disease	0.000164	0.000558	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000164	0.00199	CbGpPWpGaD
Lorazepam—Asthenia—Captopril—coronary artery disease	0.000163	0.000554	CcSEcCtD
Lorazepam—Vomiting—Valsartan—coronary artery disease	0.000163	0.000553	CcSEcCtD
Lorazepam—Confusional state—Lisinopril—coronary artery disease	0.000162	0.000551	CcSEcCtD
Lorazepam—Hypotension—Timolol—coronary artery disease	0.000162	0.000551	CcSEcCtD
Lorazepam—Dizziness—Pravastatin—coronary artery disease	0.000162	0.00055	CcSEcCtD
Lorazepam—Vomiting—Olmesartan—coronary artery disease	0.000162	0.00055	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—MDH2—coronary artery disease	0.000162	0.00196	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—UGCG—coronary artery disease	0.000162	0.00196	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPAT—coronary artery disease	0.000162	0.00196	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLCD1—coronary artery disease	0.000162	0.00196	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000161	0.00196	CbGpPWpGaD
Lorazepam—Rash—Valsartan—coronary artery disease	0.000161	0.000548	CcSEcCtD
Lorazepam—Dermatitis—Valsartan—coronary artery disease	0.000161	0.000548	CcSEcCtD
Lorazepam—Nausea—Simvastatin—coronary artery disease	0.000161	0.000547	CcSEcCtD
Lorazepam—Clozapine—HTR7—coronary artery disease	0.000161	0.0305	CrCbGaD
Lorazepam—Rash—Olmesartan—coronary artery disease	0.00016	0.000545	CcSEcCtD
Lorazepam—Dermatitis—Olmesartan—coronary artery disease	0.00016	0.000545	CcSEcCtD
Lorazepam—Headache—Valsartan—coronary artery disease	0.00016	0.000544	CcSEcCtD
Lorazepam—GABRA1—Ion channel transport—ATP2A2—coronary artery disease	0.00016	0.00194	CbGpPWpGaD
Lorazepam—Infection—Lisinopril—coronary artery disease	0.00016	0.000543	CcSEcCtD
Lorazepam—Headache—Olmesartan—coronary artery disease	0.000159	0.000542	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000158	0.00192	CbGpPWpGaD
Lorazepam—Asthenia—Perindopril—coronary artery disease	0.000158	0.000538	CcSEcCtD
Lorazepam—Vomiting—Niacin—coronary artery disease	0.000158	0.000537	CcSEcCtD
Lorazepam—Hypersensitivity—Furosemide—coronary artery disease	0.000158	0.000537	CcSEcCtD
Lorazepam—Somnolence—Ramipril—coronary artery disease	0.000158	0.000536	CcSEcCtD
Lorazepam—Thrombocytopenia—Lisinopril—coronary artery disease	0.000157	0.000535	CcSEcCtD
Lorazepam—Dizziness—Trandolapril—coronary artery disease	0.000157	0.000534	CcSEcCtD
Lorazepam—Tachycardia—Lisinopril—coronary artery disease	0.000157	0.000533	CcSEcCtD
Lorazepam—Rash—Niacin—coronary artery disease	0.000157	0.000533	CcSEcCtD
Lorazepam—Dermatitis—Niacin—coronary artery disease	0.000157	0.000532	CcSEcCtD
Lorazepam—Dizziness—Enalapril—coronary artery disease	0.000157	0.000532	CcSEcCtD
Lorazepam—Headache—Niacin—coronary artery disease	0.000156	0.000529	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—PGM1—coronary artery disease	0.000156	0.00189	CbGpPWpGaD
Lorazepam—Vomiting—Pravastatin—coronary artery disease	0.000156	0.000529	CcSEcCtD
Lorazepam—Dizziness—Telmisartan—coronary artery disease	0.000154	0.000525	CcSEcCtD
Lorazepam—Rash—Pravastatin—coronary artery disease	0.000154	0.000525	CcSEcCtD
Lorazepam—Dermatitis—Pravastatin—coronary artery disease	0.000154	0.000524	CcSEcCtD
Lorazepam—Somnolence—Timolol—coronary artery disease	0.000154	0.000524	CcSEcCtD
Lorazepam—Asthenia—Furosemide—coronary artery disease	0.000154	0.000523	CcSEcCtD
Lorazepam—Headache—Pravastatin—coronary artery disease	0.000153	0.000521	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000153	0.00052	CcSEcCtD
Lorazepam—Fatigue—Ramipril—coronary artery disease	0.000153	0.00052	CcSEcCtD
Lorazepam—Hypersensitivity—Losartan—coronary artery disease	0.000152	0.000518	CcSEcCtD
Lorazepam—Nausea—Valsartan—coronary artery disease	0.000152	0.000516	CcSEcCtD
Lorazepam—Constipation—Ramipril—coronary artery disease	0.000152	0.000515	CcSEcCtD
Lorazepam—Nausea—Olmesartan—coronary artery disease	0.000151	0.000514	CcSEcCtD
Lorazepam—Vomiting—Trandolapril—coronary artery disease	0.000151	0.000514	CcSEcCtD
Lorazepam—Vomiting—Enalapril—coronary artery disease	0.00015	0.000512	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—PYGB—coronary artery disease	0.00015	0.00182	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CKB—coronary artery disease	0.00015	0.00182	CbGpPWpGaD
Lorazepam—Hypotension—Lisinopril—coronary artery disease	0.00015	0.000511	CcSEcCtD
Lorazepam—Dizziness—Captopril—coronary artery disease	0.00015	0.00051	CcSEcCtD
Lorazepam—Rash—Trandolapril—coronary artery disease	0.00015	0.000509	CcSEcCtD
Lorazepam—Dermatitis—Trandolapril—coronary artery disease	0.00015	0.000509	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Timolol—coronary artery disease	0.00015	0.000509	CcSEcCtD
Lorazepam—Fatigue—Timolol—coronary artery disease	0.000149	0.000508	CcSEcCtD
Lorazepam—Rash—Enalapril—coronary artery disease	0.000149	0.000507	CcSEcCtD
Lorazepam—Dermatitis—Enalapril—coronary artery disease	0.000149	0.000507	CcSEcCtD
Lorazepam—Headache—Trandolapril—coronary artery disease	0.000149	0.000506	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000149	0.00181	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000149	0.00181	CbGpPWpGaD
Lorazepam—Vomiting—Telmisartan—coronary artery disease	0.000148	0.000505	CcSEcCtD
Lorazepam—Asthenia—Losartan—coronary artery disease	0.000148	0.000504	CcSEcCtD
Lorazepam—Headache—Enalapril—coronary artery disease	0.000148	0.000504	CcSEcCtD
Lorazepam—Pain—Timolol—coronary artery disease	0.000148	0.000504	CcSEcCtD
Lorazepam—Nausea—Niacin—coronary artery disease	0.000148	0.000502	CcSEcCtD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000148	0.00179	CbGpPWpGaD
Lorazepam—Rash—Telmisartan—coronary artery disease	0.000147	0.0005	CcSEcCtD
Lorazepam—Dermatitis—Telmisartan—coronary artery disease	0.000147	0.0005	CcSEcCtD
Lorazepam—GABRB3—Neuronal System—PLCB3—coronary artery disease	0.000147	0.00178	CbGpPWpGaD
Lorazepam—Headache—Telmisartan—coronary artery disease	0.000146	0.000497	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000146	0.00177	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000146	0.00177	CbGpPWpGaD
Lorazepam—Feeling abnormal—Ramipril—coronary artery disease	0.000146	0.000497	CcSEcCtD
Lorazepam—Dizziness—Perindopril—coronary artery disease	0.000146	0.000496	CcSEcCtD
Lorazepam—GABRA1—Orphan transporters—APOB—coronary artery disease	0.000146	0.00177	CbGpPWpGaD
Lorazepam—Nausea—Pravastatin—coronary artery disease	0.000145	0.000494	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000145	0.00176	CbGpPWpGaD
Lorazepam—Vomiting—Captopril—coronary artery disease	0.000144	0.000491	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—PLCB3—coronary artery disease	0.000144	0.00175	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000144	0.00175	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000143	0.00174	CbGpPWpGaD
Lorazepam—Rash—Captopril—coronary artery disease	0.000143	0.000487	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000143	0.00174	CbGpPWpGaD
Lorazepam—Dermatitis—Captopril—coronary artery disease	0.000143	0.000486	CcSEcCtD
Lorazepam—Somnolence—Lisinopril—coronary artery disease	0.000143	0.000486	CcSEcCtD
Lorazepam—Feeling abnormal—Timolol—coronary artery disease	0.000143	0.000486	CcSEcCtD
Lorazepam—Headache—Captopril—coronary artery disease	0.000142	0.000484	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000142	0.00172	CbGpPWpGaD
Lorazepam—Dizziness—Furosemide—coronary artery disease	0.000142	0.000482	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—COX5B—coronary artery disease	0.000141	0.00172	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLIN1—coronary artery disease	0.000141	0.00172	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—DLAT—coronary artery disease	0.000141	0.00172	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTM2—coronary artery disease	0.000141	0.00172	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PFKFB3—coronary artery disease	0.000141	0.00172	CbGpPWpGaD
Lorazepam—Nausea—Trandolapril—coronary artery disease	0.000141	0.00048	CcSEcCtD
Lorazepam—Nausea—Enalapril—coronary artery disease	0.000141	0.000478	CcSEcCtD
Lorazepam—Vomiting—Perindopril—coronary artery disease	0.00014	0.000476	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000139	0.00169	CbGpPWpGaD
Lorazepam—Rash—Perindopril—coronary artery disease	0.000139	0.000473	CcSEcCtD
Lorazepam—Dermatitis—Perindopril—coronary artery disease	0.000139	0.000472	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000139	0.000472	CcSEcCtD
Lorazepam—Nausea—Telmisartan—coronary artery disease	0.000139	0.000471	CcSEcCtD
Lorazepam—Fatigue—Lisinopril—coronary artery disease	0.000139	0.000471	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000138	0.00168	CbGpPWpGaD
Lorazepam—Headache—Perindopril—coronary artery disease	0.000138	0.000469	CcSEcCtD
Lorazepam—Pain—Lisinopril—coronary artery disease	0.000137	0.000467	CcSEcCtD
Lorazepam—Constipation—Lisinopril—coronary artery disease	0.000137	0.000467	CcSEcCtD
Lorazepam—Dizziness—Losartan—coronary artery disease	0.000137	0.000465	CcSEcCtD
Lorazepam—Vomiting—Furosemide—coronary artery disease	0.000136	0.000463	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—STAT5A—coronary artery disease	0.000135	0.00164	CbGpPWpGaD
Lorazepam—Rash—Furosemide—coronary artery disease	0.000135	0.000459	CcSEcCtD
Lorazepam—Dermatitis—Furosemide—coronary artery disease	0.000135	0.000459	CcSEcCtD
Lorazepam—Nausea—Captopril—coronary artery disease	0.000135	0.000458	CcSEcCtD
Lorazepam—Headache—Furosemide—coronary artery disease	0.000134	0.000456	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—SULT1E1—coronary artery disease	0.000134	0.00163	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000133	0.00161	CbGpPWpGaD
Lorazepam—Feeling abnormal—Lisinopril—coronary artery disease	0.000132	0.00045	CcSEcCtD
Lorazepam—Vomiting—Losartan—coronary artery disease	0.000131	0.000447	CcSEcCtD
Lorazepam—Nausea—Perindopril—coronary artery disease	0.000131	0.000445	CcSEcCtD
Lorazepam—Hypersensitivity—Ramipril—coronary artery disease	0.000131	0.000444	CcSEcCtD
Lorazepam—Rash—Losartan—coronary artery disease	0.00013	0.000443	CcSEcCtD
Lorazepam—Dermatitis—Losartan—coronary artery disease	0.00013	0.000443	CcSEcCtD
Lorazepam—Headache—Losartan—coronary artery disease	0.000129	0.00044	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—AKR1B1—coronary artery disease	0.000128	0.00155	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HK2—coronary artery disease	0.000128	0.00155	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000128	0.00155	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000128	0.00155	CbGpPWpGaD
Lorazepam—Hypersensitivity—Timolol—coronary artery disease	0.000128	0.000434	CcSEcCtD
Lorazepam—Nausea—Furosemide—coronary artery disease	0.000127	0.000433	CcSEcCtD
Lorazepam—Asthenia—Ramipril—coronary artery disease	0.000127	0.000432	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000127	0.00154	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000126	0.00153	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—PLCB3—coronary artery disease	0.000126	0.00153	CbGpPWpGaD
Lorazepam—Asthenia—Timolol—coronary artery disease	0.000124	0.000423	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000124	0.0015	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MEF2C—coronary artery disease	0.000124	0.0015	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—RPS6KB1—coronary artery disease	0.000124	0.0015	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—ALDH2—coronary artery disease	0.000124	0.0015	CbGpPWpGaD
Lorazepam—Amoxapine—HTR2A—coronary artery disease	0.000123	0.0234	CrCbGaD
Lorazepam—Nausea—Losartan—coronary artery disease	0.000123	0.000418	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—SLC27A1—coronary artery disease	0.000122	0.00149	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000122	0.00148	CbGpPWpGaD
Lorazepam—Temazepam—CYP2C19—coronary artery disease	0.000121	0.023	CrCbGaD
Lorazepam—GABRG2—Neuronal System—ALDH2—coronary artery disease	0.000121	0.00147	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CPT1B—coronary artery disease	0.00012	0.00146	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LCAT—coronary artery disease	0.00012	0.00146	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000119	0.00144	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000119	0.00144	CbGpPWpGaD
Lorazepam—Hypersensitivity—Lisinopril—coronary artery disease	0.000118	0.000403	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000118	0.00143	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOA4—coronary artery disease	0.000118	0.00143	CbGpPWpGaD
Lorazepam—Diclofenac—PTGS2—coronary artery disease	0.000118	0.0223	CrCbGaD
Lorazepam—Dizziness—Ramipril—coronary artery disease	0.000117	0.000399	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—PPP2CA—coronary artery disease	0.000117	0.00142	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000117	0.00142	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000117	0.00142	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000116	0.0014	CbGpPWpGaD
Lorazepam—Asthenia—Lisinopril—coronary artery disease	0.000115	0.000392	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—PRKCD—coronary artery disease	0.000115	0.0014	CbGpPWpGaD
Lorazepam—Dizziness—Timolol—coronary artery disease	0.000115	0.00039	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—PDHA1—coronary artery disease	0.000114	0.00138	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GCLM—coronary artery disease	0.000114	0.00138	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000114	0.00138	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CAMK2D—coronary artery disease	0.000113	0.00137	CbGpPWpGaD
Lorazepam—Vomiting—Ramipril—coronary artery disease	0.000113	0.000383	CcSEcCtD
Lorazepam—Rash—Ramipril—coronary artery disease	0.000112	0.00038	CcSEcCtD
Lorazepam—Dermatitis—Ramipril—coronary artery disease	0.000112	0.00038	CcSEcCtD
Lorazepam—Headache—Ramipril—coronary artery disease	0.000111	0.000378	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—CAMK2D—coronary artery disease	0.000111	0.00135	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.00011	0.00134	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—TXNRD1—coronary artery disease	0.00011	0.00134	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP11B2—coronary artery disease	0.00011	0.00134	CbGpPWpGaD
Lorazepam—Chlorprothixene—HTR2A—coronary artery disease	0.00011	0.0209	CrCbGaD
Lorazepam—Vomiting—Timolol—coronary artery disease	0.00011	0.000375	CcSEcCtD
Lorazepam—Clonazepam—ALB—coronary artery disease	0.000109	0.0207	CrCbGaD
Lorazepam—Rash—Timolol—coronary artery disease	0.000109	0.000372	CcSEcCtD
Lorazepam—Dermatitis—Timolol—coronary artery disease	0.000109	0.000371	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—SLC22A3—coronary artery disease	0.000109	0.00132	CbGpPWpGaD
Lorazepam—Headache—Timolol—coronary artery disease	0.000109	0.000369	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000108	0.00131	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000108	0.00131	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ARNTL—coronary artery disease	0.000107	0.0013	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HADH—coronary artery disease	0.000107	0.0013	CbGpPWpGaD
Lorazepam—Dizziness—Lisinopril—coronary artery disease	0.000106	0.000361	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—ALDH2—coronary artery disease	0.000106	0.00129	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000106	0.00128	CbGpPWpGaD
Lorazepam—Nausea—Ramipril—coronary artery disease	0.000105	0.000358	CcSEcCtD
Lorazepam—Diclofenac—ALB—coronary artery disease	0.000105	0.0199	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000103	0.00125	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000103	0.00125	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000103	0.00125	CbGpPWpGaD
Lorazepam—Nausea—Timolol—coronary artery disease	0.000103	0.00035	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000102	0.00124	CbGpPWpGaD
Lorazepam—Vomiting—Lisinopril—coronary artery disease	0.000102	0.000348	CcSEcCtD
Lorazepam—GABRA1—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000102	0.00124	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000102	0.00124	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPK14—coronary artery disease	0.000102	0.00124	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLA2G2A—coronary artery disease	0.000102	0.00123	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOA2—coronary artery disease	0.000102	0.00123	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GPX2—coronary artery disease	0.000102	0.00123	CbGpPWpGaD
Lorazepam—Rash—Lisinopril—coronary artery disease	0.000101	0.000345	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000101	0.00123	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000101	0.00123	CbGpPWpGaD
Lorazepam—Dermatitis—Lisinopril—coronary artery disease	0.000101	0.000344	CcSEcCtD
Lorazepam—Diazepam—CYP2C19—coronary artery disease	0.000101	0.0191	CrCbGaD
Lorazepam—Headache—Lisinopril—coronary artery disease	0.000101	0.000342	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—ABCG5—coronary artery disease	0.0001	0.00122	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HK1—coronary artery disease	0.0001	0.00122	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SULT1A1—coronary artery disease	0.0001	0.00122	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GPX4—coronary artery disease	0.0001	0.00122	CbGpPWpGaD
Lorazepam—Clozapine—CYP2C19—coronary artery disease	9.96e-05	0.0189	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	9.96e-05	0.00121	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PLN—coronary artery disease	9.93e-05	0.00121	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HADHA—coronary artery disease	9.91e-05	0.0012	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTA1—coronary artery disease	9.79e-05	0.00119	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NFKBIA—coronary artery disease	9.75e-05	0.00118	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CAMK2D—coronary artery disease	9.7e-05	0.00118	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LPA—coronary artery disease	9.68e-05	0.00118	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—PLCB1—coronary artery disease	9.67e-05	0.00117	CbGpPWpGaD
Lorazepam—Nausea—Lisinopril—coronary artery disease	9.55e-05	0.000325	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—PLCB1—coronary artery disease	9.49e-05	0.00115	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLCB3—coronary artery disease	9.38e-05	0.00114	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOA5—coronary artery disease	9.28e-05	0.00113	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HK2—coronary artery disease	9.23e-05	0.00112	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	9.19e-05	0.00112	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	9.15e-05	0.00111	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	9.15e-05	0.00111	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—P4HB—coronary artery disease	9.1e-05	0.00111	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—GSK3B—coronary artery disease	9.06e-05	0.0011	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	9.06e-05	0.0011	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	9.02e-05	0.0011	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CREB1—coronary artery disease	8.99e-05	0.00109	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	8.98e-05	0.00109	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	8.98e-05	0.00109	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLA2G1B—coronary artery disease	8.94e-05	0.00108	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ATP4A—coronary artery disease	8.85e-05	0.00107	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	8.85e-05	0.00107	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	8.63e-05	0.00105	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCG5—coronary artery disease	8.44e-05	0.00102	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	8.44e-05	0.00102	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HK1—coronary artery disease	8.44e-05	0.00102	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—VCAN—coronary artery disease	8.42e-05	0.00102	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALDOA—coronary artery disease	8.36e-05	0.00101	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—PLCB1—coronary artery disease	8.3e-05	0.00101	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	8.29e-05	0.00101	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	8.29e-05	0.00101	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HK1—coronary artery disease	8.29e-05	0.00101	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—DCN—coronary artery disease	8.11e-05	0.000985	CbGpPWpGaD
Lorazepam—Clozapine—HTR2A—coronary artery disease	8.08e-05	0.0153	CrCbGaD
Lorazepam—UGT2B15—Metabolism—ALDH2—coronary artery disease	7.89e-05	0.000958	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	7.89e-05	0.000958	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	7.85e-05	0.000953	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	7.85e-05	0.000953	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LIPC—coronary artery disease	7.69e-05	0.000934	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HBA1—coronary artery disease	7.69e-05	0.000934	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3C2A—coronary artery disease	7.69e-05	0.000934	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP2C19—coronary artery disease	7.69e-05	0.000934	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOC3—coronary artery disease	7.64e-05	0.000928	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—JAK2—coronary artery disease	7.62e-05	0.000925	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LDLR—coronary artery disease	7.6e-05	0.000922	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTT1—coronary artery disease	7.51e-05	0.000911	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC9A1—coronary artery disease	7.51e-05	0.000911	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GCLC—coronary artery disease	7.42e-05	0.000901	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CETP—coronary artery disease	7.42e-05	0.000901	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SDC1—coronary artery disease	7.34e-05	0.000891	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	7.25e-05	0.00088	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HK1—coronary artery disease	7.25e-05	0.00088	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	7.25e-05	0.00088	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CREB1—coronary artery disease	7.23e-05	0.000878	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL6R—coronary artery disease	7.06e-05	0.000857	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PSMA6—coronary artery disease	6.93e-05	0.000842	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PSMB5—coronary artery disease	6.93e-05	0.000842	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CREB1—coronary artery disease	6.91e-05	0.000839	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CREB1—coronary artery disease	6.78e-05	0.000824	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CTGF—coronary artery disease	6.77e-05	0.000822	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HMGCR—coronary artery disease	6.71e-05	0.000815	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GOT2—coronary artery disease	6.71e-05	0.000815	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CASP3—coronary artery disease	6.65e-05	0.000808	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	6.48e-05	0.000786	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	6.36e-05	0.000772	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	6.32e-05	0.000767	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—CETP—coronary artery disease	6.25e-05	0.000759	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	6.21e-05	0.000754	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLCB1—coronary artery disease	6.17e-05	0.000749	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—CETP—coronary artery disease	6.14e-05	0.000745	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ABCA1—coronary artery disease	5.98e-05	0.000726	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CREB1—coronary artery disease	5.93e-05	0.00072	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.92e-05	0.000719	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.82e-05	0.000706	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GGT1—coronary artery disease	5.79e-05	0.000703	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GOT1—coronary artery disease	5.79e-05	0.000703	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	5.6e-05	0.000679	CbGpPWpGaD
Lorazepam—Diazepam—ALB—coronary artery disease	5.6e-05	0.0106	CrCbGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	5.56e-05	0.000675	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PLAT—coronary artery disease	5.51e-05	0.000669	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	5.43e-05	0.000659	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PLAT—coronary artery disease	5.41e-05	0.000657	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—coronary artery disease	5.37e-05	0.000652	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—CETP—coronary artery disease	5.36e-05	0.000651	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—coronary artery disease	5.36e-05	0.00065	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CREB1—coronary artery disease	5.29e-05	0.000643	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTP1—coronary artery disease	5.2e-05	0.000632	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CREB1—coronary artery disease	5.2e-05	0.000631	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	5.2e-05	0.000631	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARGC1A—coronary artery disease	5.16e-05	0.000626	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HMOX1—coronary artery disease	5.13e-05	0.000623	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	5.1e-05	0.00062	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.08e-05	0.000617	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPK1—coronary artery disease	5.08e-05	0.000617	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CAT—coronary artery disease	5.06e-05	0.000615	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOB—coronary artery disease	4.92e-05	0.000597	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTM1—coronary artery disease	4.78e-05	0.000581	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PLAT—coronary artery disease	4.73e-05	0.000574	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LPL—coronary artery disease	4.69e-05	0.00057	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PLG—coronary artery disease	4.68e-05	0.000568	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PLG—coronary artery disease	4.6e-05	0.000558	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GPX1—coronary artery disease	4.58e-05	0.000556	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	4.55e-05	0.000552	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CREB1—coronary artery disease	4.54e-05	0.000552	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	4.46e-05	0.000542	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CD36—coronary artery disease	4.46e-05	0.000541	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPP2CA—coronary artery disease	4.4e-05	0.000535	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.32e-05	0.000525	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.24e-05	0.000515	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTHFR—coronary artery disease	4.23e-05	0.000513	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—APOB—coronary artery disease	4.14e-05	0.000503	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—APOB—coronary artery disease	4.06e-05	0.000493	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PLG—coronary artery disease	4.02e-05	0.000488	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AGT—coronary artery disease	4.02e-05	0.000488	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOE—coronary artery disease	3.93e-05	0.000478	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.91e-05	0.000474	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TNF—coronary artery disease	3.9e-05	0.000473	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOA1—coronary artery disease	3.89e-05	0.000472	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.84e-05	0.000466	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	3.71e-05	0.00045	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—AKT1—coronary artery disease	3.6e-05	0.000437	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—APOB—coronary artery disease	3.55e-05	0.000431	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARG—coronary artery disease	3.43e-05	0.000416	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—POMC—coronary artery disease	3.38e-05	0.00041	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.35e-05	0.000407	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.28e-05	0.000398	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.22e-05	0.00039	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL6—coronary artery disease	3.14e-05	0.000382	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALB—coronary artery disease	3.08e-05	0.000374	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—MAPK1—coronary artery disease	2.99e-05	0.000363	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NOS3—coronary artery disease	2.95e-05	0.000358	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—MAPK1—coronary artery disease	2.94e-05	0.000357	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.81e-05	0.000341	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTGS2—coronary artery disease	2.7e-05	0.000327	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ALB—coronary artery disease	2.59e-05	0.000315	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—MAPK1—coronary artery disease	2.57e-05	0.000312	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ALB—coronary artery disease	2.55e-05	0.000309	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.23e-05	0.00027	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CA—coronary artery disease	1.66e-05	0.000201	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AKT1—coronary artery disease	1.36e-05	0.000165	CbGpPWpGaD
